Company: IMNN
Filing Date: 2025-04-04
Form Type: S-1
Source: 0001641172-25-002783
Chunk: 6

Company: Imunon, Inc.
Filing Date: 2025-04-04
Form: S-1
Chunk 6
---
 revised or supplemented by our subsequent Quarterly Reports on Form 10-Q, which are incorporated herein by reference, for a discussion of information that you should consider before investing in our securities.

Neither the Securities and Exchange Commission (the “ SEC”) nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

|                           |     | Per          
 Share and    
 Accompanying 
 Common       
 Warrant      |     | Per          
 Pre-Funded   
 Warrant and  
 Accompanying 
 Common       
 Warrant      |     | Total |
|:--------------------------|:----|:-------------|:----|:-------------|:----|:------|
| Public                    
 offering price(1)         |     | $            |     | $            |     | $     |
| Placement                 
 Agent fees(2)             |     | $            |     | $            |     | $     |
| Proceeds                  
 to us, before expenses(3) |     | $            |     | $            |     | $     |

| (1) | The                                                             
 combined public offering price is $                             
 per share of Common Stock and accompanying common warrant (or $ 
 per pre-funded warrant and accompanying common warrant).        |

| (2) | Represents                                                                                                                         
 a cash fee equal to seven percent (7.0%) of the aggregate purchase price paid by investors in this offering. We have also agreed   
 to reimburse the Placement Agents for their accountable offering-related legal expenses in an amount up to $75,000 and $20,000 for 
 non-accountable expenses. See “Plan of Distribution” for additional disclosure regarding compensation payable                      
 to the Placement Agents.                                                                                                           |

Because there is no minimum number of securities or amount of proceeds required as a condition to closing this offering, the actual public offering amount, Placement Agent fees, and proceeds to us, if any, are not presently determinable and may be substantially less than the total maximum offering amounts set forth above. See “ Plan of Distribution” for more information.

| (3) | Does                                                                                                      
 not include proceeds from the exercise of the common warrants and/or pre-funded warrants in cash, if any. |

Delivery of the securities is expected to be made on or about , 2025, subject to satisfaction of certain conditions.

<div align='center'>Lead Placement Agent

A.G.P.

Co-Placement Agent

Brookline Capital Markets

a division of